KBC Group NV Sells 9,537 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

KBC Group NV cut its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.7% in the fourth quarter, Holdings Channel reports. The fund owned 248,923 shares of the medical device company’s stock after selling 9,537 shares during the period. KBC Group NV’s holdings in Cooper Companies were worth $22,884,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in COO. Public Sector Pension Investment Board boosted its position in Cooper Companies by 71.7% in the second quarter. Public Sector Pension Investment Board now owns 7,590 shares of the medical device company’s stock valued at $663,000 after buying an additional 3,170 shares in the last quarter. MBB Public Markets I LLC bought a new position in shares of Cooper Companies in the second quarter valued at approximately $1,261,000. Magnolia Capital Advisors LLC acquired a new position in shares of Cooper Companies in the 2nd quarter worth approximately $211,000. Northwestern Mutual Wealth Management Co. grew its position in Cooper Companies by 23.4% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,868 shares of the medical device company’s stock worth $163,000 after acquiring an additional 354 shares during the last quarter. Finally, Wallace Advisory Group LLC acquired a new stake in Cooper Companies during the 2nd quarter valued at $290,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Morgan Stanley reduced their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Wells Fargo & Company upped their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, Citigroup lowered their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $98.50 on Wednesday. The Cooper Companies, Inc. has a 52 week low of $84.76 and a 52 week high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market capitalization of $19.66 billion, a price-to-earnings ratio of 50.51, a PEG ratio of 2.41 and a beta of 0.99. The firm has a fifty day moving average of $95.94 and a two-hundred day moving average of $99.55.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.87 earnings per share. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.